Login

4th Conference on PET/MR and SPECT/MR

17–20 May 2015
La Biodola, Isola d'Elba
Europe/Rome timezone

<b>Email</b>

Session

Session 13 - Clinical MR-PET

20 May 2015, 18:00
La Biodola, Isola d'Elba

La Biodola, Isola d'Elba

<a target="_blank" href=http://www.elba4star.it/HH/index-Eng.html>Hotel Hermitage</a> </br>e-mail: <a href="mailto:psmr2015@df.unipi.it"> psmr2015@df.unipi.it

Conveners

Session 13 - Clinical MR-PET

  • Irene Neuner (JARA Brain)

Presentation materials

There are no materials yet.

  1. 98. Quantitative impact of Dixon µmap variability in dual-time-point brain PET/MR
    Ms Kimberly Jackson (Center for Biomedical Imaging, Department of Radiology, NYU Langone Medical Center, New York, NY USA)
    20/05/2015, 18:00
    7 - Clinical MR-PET
    Talk
    Background: Dixon-based MR is acquired for attenuation correction of brain PET during PET/MR. Early adopters of PET/MR have noted variability in the performance of Dixon-based tissue segmentation, and questions exist regarding potential impacts on quantitative accuracy in dual-time-point studies. Methods: Ten patients injected with 10 mCi FDG underwent dual-time-point clinical brain...
    Go to contribution page
  2. 93. Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR
    Dr Maged Goubran (Stanford University), Dr Michael Zeineh (Stanford University)
    20/05/2015, 18:20
    7 - Clinical MR-PET
    Talk
    Alzheimer’s disease (AD) has been reported to show decreased metabolic activity in the hippocampus using FDG PET-MR. Histological data suggests that the hippocampal subfields are selectively affected in AD. Given the simultaneous imaging nature of integrated PET-MR scanners and the multimodal capabilities of PET-MR, our purpose here is to assess FDG activity, as well as ASL perfusion in the...
    Go to contribution page
Building timetable...